ACAD
30.3
-1.13
-3.60%
AEMD
5.88
-0.13
-2.16%
APRI
0.367
-0.033
-8.250%
ARNA
1.65
-0.16
-8.84%
ATEC
0.301
+0.021
+7.500%
CNAT
2
0.00
N/A%
CRXM
0.16
-0.015
-8.6015%
CYTX
2
-0.02
-0.99%
DXCM
75.91
-1.55
-2.00%
GNMK
8.14
-0.21
-2.51%
HALO
7.78
0.00
N/A%
ILMN
135.48
-3.43
-2.47%
INNV
0.215
-0.015
-6.522%
INO
8.29
-0.88
-9.60%
ISCO
1.91
-0.14
-6.83%
ISIS
57.56
0.00
0.00%
LGND
113.12
+1.33
+1.19%
LPTN
2.05
-0.13
-5.96%
MBVX
0.55
0.00
-0.45%
MEIP
1.27
-0.09
-6.62%
MNOV
6.96
-0.04
-0.57%
MRTX
5.55
-0.43
-7.19%
MSTX
0.464
+0.014
+3.203%
NBIX
41.79
-1.49
-3.44%
NUVA
57.79
-0.14
-0.24%
ONCS
1.59
-0.04
-2.45%
ONVO
3.1
-0.25
-7.46%
OREX
0.41
-0.039
-8.5784%
OTIC
14.93
-0.65
-4.17%
QDEL
16.67
-0.42
-2.46%
RCPT
231.96
0.00
0.00%
RGLS
5.01
-0.28
-5.29%
RMD
59.22
-1.3
-2.15%
SCIE
0.004
-0.001
-13.7255%
SPHS
1.72
-0.14
-7.53%
SRNE
5.49
-0.13
-2.31%
TROV
4.36
-0.19
-4.18%
VICL
4.22
-0.25
-5.59%
VOLC
18
0.00
0.00%
ZGNX
7.35
-0.74
-9.15%
ACAD
30.3
-1.13
-3.60%
AEMD
5.88
-0.13
-2.16%
APRI
0.367
-0.033
-8.250%
ARNA
1.65
-0.16
-8.84%
ATEC
0.301
+0.021
+7.500%
CNAT
2
0.00
N/A%
CRXM
0.16
-0.015
-8.6015%
CYTX
2
-0.02
-0.99%
DXCM
75.91
-1.55
-2.00%
GNMK
8.14
-0.21
-2.51%
HALO
7.78
0.00
N/A%
ILMN
135.48
-3.43
-2.47%
INNV
0.215
-0.015
-6.522%
INO
8.29
-0.88
-9.60%
ISCO
1.91
-0.14
-6.83%
ISIS
57.56
0.00
0.00%
LGND
113.12
+1.33
+1.19%
LPTN
2.05
-0.13
-5.96%
MBVX
0.55
0.00
-0.45%
MEIP
1.27
-0.09
-6.62%
MNOV
6.96
-0.04
-0.57%
MRTX
5.55
-0.43
-7.19%
MSTX
0.464
+0.014
+3.203%
NBIX
41.79
-1.49
-3.44%
NUVA
57.79
-0.14
-0.24%
ONCS
1.59
-0.04
-2.45%
ONVO
3.1
-0.25
-7.46%
OREX
0.41
-0.039
-8.5784%
OTIC
14.93
-0.65
-4.17%
QDEL
16.67
-0.42
-2.46%
RCPT
231.96
0.00
0.00%
RGLS
5.01
-0.28
-5.29%
RMD
59.22
-1.3
-2.15%
SCIE
0.004
-0.001
-13.7255%
SPHS
1.72
-0.14
-7.53%
SRNE
5.49
-0.13
-2.31%
TROV
4.36
-0.19
-4.18%
VICL
4.22
-0.25
-5.59%
VOLC
18
0.00
0.00%
ZGNX
7.35
-0.74
-9.15%
Home » Archive by Category

Xconomy

Biotech Roundup: Duchenne Delay, Forum’s Fate, Califf, Ionis & More

May 27, 2016 – 5:40 am

Memorial Day weekend may be fast approaching, but don’t fire up those grills yet: there’s plenty of headlines to dig into first in our biotech trip around the Xconomy network. In New York, the…

[[Click headline to continue reading.]]

FDA Commish Califf to Big Data Crowd: Flood Of New Treatments Coming

May 26, 2016 – 1:31 pm

New FDA commissioner Robert Califf said Wednesday that the recent spike in drug approvals is no temporary phenomenon, thanks to a better understanding of biology and continued adoption of…

[[Click headline to continue reading.]]

Sophiris Streamlines Operations, Weighs Options on Prostate Drug

May 24, 2016 – 11:53 pm

[Updated 5/25/16 2:35 pm with analyst comments. See below.] After advancing its experimental prostate drug to late-stage clinical trials, San Diego-based Sophiris Bio (NASDAQ: SPHS) has been…

[[Click headline to continue reading.]]

The Biotech Roundup: Immunotherapy Ups And Downs, Gene Deals & More

May 20, 2016 – 3:30 am

A quick housekeeping note: Starting this week, we are combining our East Coast and West Coast biotech roundups into a single weekly post that will also include highlights from our other cities and…

[[Click headline to continue reading.]]

Biogen Turns To UPenn Gene Therapy Pioneers in Wide-Ranging Alliance

May 16, 2016 – 3:55 am

Even though it recently decided to unload a gene therapy for hemophilia into a yet-to-be-named spin-out company, Biogen, one of biotech’s most risk-taking firms, is doubling down on gene…

[[Click headline to continue reading.]]

White House Wants to Spend $121M on National Microbiome Initiative

May 13, 2016 – 12:35 pm

The Obama administration announced this morning a public-private initiative to study the collections of microorganisms that live on or in humans and practically everywhere else on Earth. More than…

[[Click headline to continue reading.]]

MGH Goes Epic: What I Learned in the Trenches

May 10, 2016 – 5:45 am

On April 2 at Massachusetts General Hospital (MGH), the green charts went away. Every morning around 6:30 am since starting residency, my co-interns and I had frantically scrambled around the halls…

[[Click headline to continue reading.]]

Across The Board: Ideas To Narrow Biotech’s Gender Gap

May 10, 2016 – 3:30 am

The evidence is piling up. Companies with more women in charge are better businesses. So why are so many biotechs still led mainly by men? Saira Ramasastry, a former Merrill Lynch analyst, is now a…

[[Click headline to continue reading.]]

West Coast Biotech Roundup: Acadia, Medivation, Verily, and More

May 6, 2016 – 5:40 am

Just a few weeks ago, the Silicon Valley tech entrepreneur and philanthropist Sean Parker committed $250 million of his Napster and Facebook fortune to a massive effort to accelerate ways to boost…

[[Click headline to continue reading.]]

More than a Matter of Appearances: Pharma’s Existential PR Problem

May 5, 2016 – 2:40 am

When President Obama forced Pfizer to scrap its proposed $160 billion merger with Allergan, the industry as well as the company emerged as losers in the eyes of the public, despite Pfizer’s credible…

[[Click headline to continue reading.]]